Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03149549
Recruitment Status : Completed
First Posted : May 11, 2017
Last Update Posted : August 4, 2021
Sponsor:
Information provided by (Responsible Party):
CytomX Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 10, 2020
Actual Study Completion Date : September 10, 2020
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 1, 2021